Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

anti-TAB3 (TAB3) Antikörper

Bezeichnung:: anti-TGF-beta Activated Kinase 1/MAP3K7 Binding Protein 3 Antikörper (TAB3)

Auf www.antikoerper-online.de finden Sie aktuell 102 TGF-beta Activated Kinase 1/MAP3K7 Binding Protein 3 (TAB3) Antikörper von 18 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen TAB3 Kits (7) und TAB3 Proteine (4) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 120 TAB3 Produkte verfügbar.

Synonyme:: 4921526G09Rik, map3k7ip3, map3k7ip3l, mKIAA4135, NAP1, si:ch211-232d19.8, si:dkey-30h22.6

Alle Antikörper anzeigen	Gen	GeneID	UniProt
	TAB3	257397	Q8N5C8
	TAB3	66724	Q571K4
	TAB3	317546
Alle Spezies anzeigen Weitere Synonyme anzeigen

Meistgesuchte Reaktivitäten zu anti-TAB3 (TAB3) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Human TAB3 Antikörper:

anti-Mouse (Murine) TAB3 Antikörper:

anti-Rat (Rattus) TAB3 Antikörper:

Alle verfügbaren anti-TAB3 Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Verknüpfte Pathways mit anti-TAB3 Antikörper

Weitere Produktkategorien zu TAB3 Antikörper

Am meisten referenzierte anti-TAB3 Antikörper

Human Polyclonal TAB3 Primary Antibody für ELISA - ABIN548013 : Lu, Lin, Huang, Kang, Rich, Lo, Myszka, Han, Wu: XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization. in Molecular cell 2007 (PubMed)

Weitere Antikörper gegen TAB3 Interaktionspartner

Human TGF-beta Activated Kinase 1/MAP3K7 Binding Protein 3 (TAB3) Interaktionspartner

TAB3 may play a significant role at the level of T-cell activation and may also be a candidate biomarker for peanut allergy.
these results demonstrated that TAB3 may be a promising therapeutic target for the treatment of Esophageal squamous cell carcinoma.
The combination of WES, genomic triangulation, and systems biology has uncovered perturbations in TGF-beta activated kinase 1 signaling as a novel pathogenic substrate for polyvalvular syndrome.
Our study provides insights into the mechanism of TAB3 regulating activity and suggests its important implications in triple negative breast cancer metastasis.
Data show that knockdown of transforming growth factor-activated kinase 1 (TAK1)-binding protein 3 (TAB3) inhibited proliferation of non-small cell lung cancer (NSCLC) cells.
TAB3 regulated ovarian cancer cell bioactivity and chemotherapy performance via the NF-kappaB pathway.
Upregulation of miR-532-5p and subsequent suppression of the SESTD1 and TAB3 genes represent an antiviral response aimed at limiting West Nile virus infection.
miR-30a in MSCs may participate in the immune dysregulation of the maternal-fetal interface during PE
miR-26b suppresses NF-kappaB signaling and sensitizes hepatocellular carcinoma cells to doxorubicin-induced apoptosis by inhibiting the expression of TAK1 and TAB3.
conclude that TRIM38 negatively regulates TNFalpha- and IL-1beta-induced signaling by mediating lysosome-dependent degradation of TAB2/3, two critical components in TNFalpha- and IL-1beta-induced signaling pathways
Studies show that three proteins expressed in HEK-293T cells (NAP1, TANK and TBKBP1) interact with TBK1.
MiR-23b suppresses IL-17-, tumor necrosis factor alpha (TNF-alpha)- or IL-1beta-induced NF-kappaB activation and inflammatory cytokine expression by targeting TAB2, TAB3 and IKK-alpha.
human TAB2 and TAB3, ubiquitin-chain sensory proteins involved in NF-kappaB signalling, are directly inactivated by enteropathogenic Escherichia coli NleE, a conserved bacterial type-III-secreted effector responsible for blocking host NF-kappaB signalling
These results point to the existence of an autophagy-stimulatory 'switch' whereby TAB2 and TAB3 abandon inhibitory interactions with Beclin 1 to engage in a stimulatory liaison with TAK1.
TAB3 is involved in IL-1-induced NF-kappaB activation by physically linking TAK1 to TRAF6.
Identification of TAB3 as a binding partner of the protein kinase TAK1.
TAB3 transforming growth factor is a constituent of the NF-kappaB pathway functioning upstream of tumor necrosis factor alpha-associated factor 6/transforming growth factor beta-activated kinase
Data show that TAB2 and TAB3 are receptors that bind preferentially to polyubiquitin chains through a highly conserved zinc finger (ZnF) domain, and activate NF-kappa B and IKK.
The TAB2/TAB3 interaction with TAK1 is crucial for the activation of signaling cascades mediated by interleukin-1, tumor necrosis factor, and receptor activator of nuclear factor-kappa B ligand (RANKL).

Mouse (Murine) TGF-beta Activated Kinase 1/MAP3K7 Binding Protein 3 (TAB3) Interaktionspartner

Findings indicate that the absence of TAB3 plays a harmful role in ischemic heart disease
TAB2 and TAB3 are essential for B cell activation leading to antigen-specific antibody responses, as well as B-1 and marginal zone B cell development.
MiR-23b suppresses IL-17-, tumor necrosis factor alpha (TNF-alpha)- or IL-1beta-induced NF-kappaB activation and inflammatory cytokine expression by targeting TAB2, TAB3 and IKK-alpha.

TAB3 Antigen-Profil

Beschreibung des Gens

The product of this gene functions in the NF-kappaB signal transduction pathway. The encoded protein, and the similar and functionally redundant protein MAP3K7IP2/TAB2, forms a ternary complex with the protein kinase MAP3K7/TAK1 and either TRAF2 or TRAF6 in response to stimulation with the pro-inflammatory cytokines TNF or IL-1. Subsequent MAP3K7/TAK1 kinase activity triggers a signaling cascade leading to activation of the NF-kappaB transcription factor. The human genome contains a related pseudogene. Alternatively spliced transcript variants have been described, but their biological validity has not been determined.

Alternative names and synonyms associated with TAB3

TGF-beta activated kinase 1 and MAP3K7 binding protein 3 (TAB3) Antikörper
TGF-beta activated kinase 1/MAP3K7 binding protein 3 (Tab3) Antikörper
TGF-beta activated kinase 1/MAP3K7 binding protein 3 (tab3) Antikörper
TGF-beta activated kinase 1 and MAP3K7 binding protein 3 (Tab3) Antikörper

4921526G09Rik Antikörper
map3k7ip3 Antikörper
map3k7ip3l Antikörper
mKIAA4135 Antikörper
NAP1 Antikörper
si:ch211-232d19.8 Antikörper
si:dkey-30h22.6 Antikörper

Bezeichner auf Proteinebene für TAB3

NF-kappa-B-activating protein 1 , NFkB activating protein 1 , TAB-3 , TAK1-binding protein 3 , TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 , TGF-beta-activated kinase 1-binding protein 3 , mitogen-activated protein kinase kinase kinase 7 interacting protein 3 , mitogen activated protein kinase kinase kinase 7 interacting protein 3 , mitogen-activated protein kinase kinase kinase 7-interacting protein 3 , TGF-beta activated kinase 1/MAP3K7 binding protein 3 , mitogen-activated protein kinase kinase kinase 7-interacting protein 3-like , mitogen-activated protein kinase kinase kinase 7 interacting protein 3 like , LOW QUALITY PROTEIN: TGF-beta-activated kinase 1 and MAP3K7-binding protein 3

GENE ID	SPEZIES
257397	Homo sapiens
66724	Mus musculus
100018532	Monodelphis domestica
100401610	Callithrix jacchus
100464125	Ailuropoda melanoleuca
100517796	Sus scrofa
100546234	Meleagris gallopavo
100580022	Nomascus leucogenys
788288	Bos taurus
491807	Canis lupus familiaris
566547	Danio rerio
317546	Rattus norvegicus

Ausgewählte Anbieter für anti-TAB3 (TAB3) Antikörper

Haben Sie etwas anderes gesucht?

Telefon:	+1 877 302 8632
Fax:	+1 888 205 9894 (Toll-free)
E-Mail:	orders@antikoerper-online.de

Show all anti-TGF-beta Activated Kinase 1/MAP3K7 Binding Protein 3 (TAB3) Antikörper with Pubmed References

Human TGF-beta Activated Kinase 1/MAP3K7 Binding Protein 3 (TAB3) Interaktionspartner

Mouse (Murine) TGF-beta Activated Kinase 1/MAP3K7 Binding Protein 3 (TAB3) Interaktionspartner

Beschreibung des Gens

Alternative names and synonyms associated with TAB3

Bezeichner auf Proteinebene für TAB3